The historical rank and industry rank for Lincoln Pharmaceuticals's FCF Margin % or its related term are showing as below:
NSE:LINCOLN'
s FCF Margin % Range Over the Past 10 Years
Min: 2.12 Med: 8.58 Max: 17.97
Current: 11.97
During the past 13 years, the highest FCF Margin % of Lincoln Pharmaceuticals was 17.97%. The lowest was 2.12%. And the median was 8.58%.
NSE:LINCOLN's FCF Margin % is ranked better than 75.29% of 955
companies
in the Drug Manufacturers industry
Industry Median: 2.51
vs NSE:LINCOLN: 11.97
Lincoln Pharmaceuticals FCF Margin % Related Terms
Lincoln Pharmaceuticals FCF Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Lincoln Pharmaceuticals's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Lincoln Pharmaceuticals FCF Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Lincoln Pharmaceuticals's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Lincoln Pharmaceuticals's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Lincoln Pharmaceuticals (NSE:LINCOLN) has a FCF Margin % of 0.00% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Lincoln Pharmaceuticals and its competitors. Over the past decade, Lincoln Pharmaceuticals' FCF Margin % has ranged from 2.12 to 17.97. According to the industry distribution chart, Lincoln Pharmaceuticals ranks #236 out of 955 companies in the Drug Manufacturers industry, placing it in the top 24.7%.
Is Lincoln Pharmaceuticals' FCF Margin % too high?
Lincoln Pharmaceuticals' current FCF Margin % is 0.00%. Over the past 10 years, this metric has ranged from a low of 2.12 to a high of 17.97. Based on the distribution chart, Lincoln Pharmaceuticals ranks #236 out of 955 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Lincoln Pharmaceuticals has a GF Score™ of 76/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Lincoln Pharmaceuticals' FCF Margin % compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Lincoln Pharmaceuticals ranks #236 out of 955 companies for FCF Margin %. This places Lincoln Pharmaceuticals in the top 25% of its industry — outperforming the majority of peers. The industry median FCF Margin % is 2.51. Historically, Lincoln Pharmaceuticals' own FCF Margin % has ranged from 2.12 to 17.97 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Drug Manufacturers company?
The median FCF Margin % among Drug Manufacturers companies is 2.51, based on 955 companies in the industry. Companies in the top quartile (top 25%) have a FCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Lincoln Pharmaceuticals and its competitors. For the Drug Manufacturers industry, the median FCF Margin % is 2.51 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Lincoln Pharmaceuticals's current FCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lincoln Pharmaceuticals stock overvalued right now?
Based on GuruFocus' analysis, Lincoln Pharmaceuticals (NSE:LINCOLN) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹701.36, compared to a current price of ₹631.55 — trading 10% below its estimated fair value. The current FCF Margin % is 0.00%. Lincoln Pharmaceuticals' overall GF Score™ is 76/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Lincoln Pharmaceuticals (NSE:LINCOLN), the current FCF Margin % is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Lincoln Pharmaceuticals (NSE:LINCOLN) Overvalued in 2026?
Based on GuruFocus' analysis, Lincoln Pharmaceuticals stock appears to be undervalued.
The current stock price of ₹631.55 is trading 10% below its estimated GF Value™ of ₹701.36.
GuruFocus considers Lincoln Pharmaceuticals to be Modestly Undervalued.
Key valuation signals for NSE:LINCOLN:
FCF Margin %: 0.00%
GF Value™: ₹701.36 vs. price of ₹631.55 (10% below fair value)
No single metric tells the full story. See the NSE:LINCOLN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Lincoln Pharmaceuticals Ltd is an India-based company engaged in the business of manufacturing and trading of pharmaceutical products. It offers products in the fields of cardiac, diabetic, anti-malarial, anti-biotic, anti-fungal, cephalosporin, analgesics, anesthetics, anti-pyretic, GIT products, vitamin-minerals, and iron preparations. Some of the key brands through which the company markets its products are; Rhino, Binafin, Kezolin, Hepalin, Progut, and Vomistat among others. Geographically, it carries out sales in India and outside India; generating key revenue from outside India.
76GF Score
Get the complete analysis for NSE:LINCOLN
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:LINCOLN has been successfully added to your 
